维普期刊资源整合服务平台（V6.5）

77篇 您的检索式：作者名="Harpole DH"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival显示文摘	Kinch MS Moore MB Harpole DH Jr	2003	Clin Cancer Res2003，9，2：	1
2	Pulmonary segmenteeto- my by thoraeotomy or thoracoscopy: reduced hospital length of stay with a minimally-invasive approach 显示文摘	Atkins BZ Harpole DH Jr Mangum JH	2010	Ann Thorac Surg2010，84，4：	1
3	Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients:clinical implications显示文摘	Kwiatkowski DJ Harpole DH Godleski J	1998	J Clin Oncol1998，16，7：	1
4	Analysis of 940 cases of pulmonary metastatic melanoma 显示文摘	Harpole DH Johnson CM Wolfe WG	1992	J Thorac Cardiovasc Surg1992，103，：	1
5	Outcomes after esophagectomy : a ten-year prospective cohort 显示文摘	Bailey SH Bull DA Harpole DH	2003	Ann Thorac Surg2003，75，1：	1
6	The society of thoracic sur- geons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction 显示文摘	Little AG Lerut AE Harpole DH	2014	Ann Tho- rac Surg2014，98，5：	1
7	Tumor marker ex- pression is predictive of survival in patients with esophageal cancer显示文摘	Aloia TA Harpole DH Jr Reed CE	2001	Ann Thorac Surg2001，72，3：	1
8	Impact of computedtomography-positron emission tomography fusion in staging patients with thoracic malignancies 显示文摘	Dlamico TA Wong TZ Harpole DH	2002	Ann Thorac Surg2002，74，1：	1
9	Noninvasive clinical staging modalities for lung cancer 显示文摘	Lau CL Harpole DH Jr	2000	Semin Surg Oncol2000，18，：	1
10	Angiogenesis and molecular biologic substaging in patients with stage Ⅰ non-small cell lung cance 显示文摘	Harpole DH Richards WG Hernedon JE	1999	Ann Thorac Surg1999，61，5：	1
11	Molecular pathologic substaging in 244 stage I non-small cell lung cancer patients: clinical implications显示文摘	Kwiatkowski DJ Harpole DH Jr Godleski J	1998	J Clin Oncol1998，16，7：	1
12	Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias显示文摘	L MJ	1996	Ann Thorac Surg1996，61，3：	1
13	A prognostic modeI recurrence and death in stage Ⅰ non-small cell lung cancer utilizing presentation,histopathology,and oncoprotein expression显示文摘	Harpole DH Jr Hemdon JE Wolf WG	1995	Cancer Res1995，，55：	1
14	Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhy thmias显示文摘	Harpole DH Liptay MJ Decanp MM	1996	Ann Thorac Surg1996，61，3：	1
15	Correlation of FDG-PET imaging with GLUT-1 and GLUT-3 expression in early-stage on small-cell lung cancer显示文摘	Marom EM Aloia TA Moore MB Hara M Herndon JE 2nd Harpole DH Jr	2001	Lung Cancer2001，33，223：	1
16	Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias 显示文摘	Harpole DH Liptay M J Decamp MM	1996	Ann Thorcic Surg1996，61，3：	1
17	The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer显示文摘	Harpole DH Jr Moore MB Hemdon JE 2nd	2001	Clin Cancer Res2001，7，3：	1
18	Correlation of tumor size and survival in patients with stageⅠa non-small cell lung cancer显示文摘	Rossi S Harpole DH	2000	Chest2000，117，6：	1
19	Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival 显示文摘	KINCH MS MOORE MB HARPOLE DH JR	2003	Clin Cancer Res2003，9，2：	1
20	A genomic strategy to refine prognosis in early stage non-small cell lung carcinoma ( NSCLC ) 显示文摘	Harpole DH Petersen R Mukherjee S	2006	J Clin Oncol2006，24，18：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示